The ASCO International Cancer Research Scholars Program

The ASCO International Cancer Research Scholars Program is a new initiative designed to support early-career researchers in cancer research globally. This program aims to foster collaboration, provide mentorship, and enhance the research skills of scholars from diverse backgrounds. Participants typically engage in training, networking opportunities, and may receive funding to advance their projects. It’s a great opportunity for those looking to make significant contributions to the field of oncology.

In connection to this program Julie Gralow shared a post on her X account:

The training will be delivered both in-person and virtually, with a 2-day workshop in São Paulo, Brazil on October 31 and November 1, hosted by Hospital Sirio Libanes, followed by quarterly online learning sessions and additional virtual networking and learning opportunities. Sessions will include information on pairing research ideas to appropriate trial designs, developing suitable biostatistical plans for research, common-sense oncology research, avoid bias, publishing, and applying for grants.

The following individuals were selected for the 2024-2025 ASCO International Cancer Research Scholars:

• Ivan Macharashvili, MD, Hospital Italiano de Buenos Aires, Argentina

• Federico Waisberg, MD, Instituto Alexander Fleming, Argentina

• Flávia Amaral Duarte, MD, MSc, Grupo Oncoclinicas, Belo Horizonte, Brazil

• Thaiana Aragão Santana, MD, MSc, Grupo Oncoclinicas, Aracaju, Brazil

• Luciana de Moura Leite, MD, AC Camargo Cancer Center, Brazil

• Giselle de Souza Carvalho, MD, MBA, Instituto Nacional de Câncer, Brazil

• Tercia Reis Villasboas, MD, Grupo Oncoclinicas, Sao Paulo, Brazil

• Heloisa Resende, MD, PhD, Hospital Hinja, Brazil

• Daniel Vargas Pivato de Almeida, MD, Grupo Oncoclinicas, Brasilia, Brazil

• Javier Retamales, MD, Hospital Sotero del Rio, Chile

• William Armando Mantilla Duran, MD, MSc, Fundación CTIC, Colombia

• Luis Ayala, MD, SOLCA Quito Hospital, Ecuador

• Rafael Correa Cano, MD, MHA, Instituto Mexicano de Seguridad Social, Mexico

• Eduardo González-Ochoa, MD, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico

• Jose Luis Portugal del Pino, MD, Oncosalud, Peru

• Patricia Rioja, MD, Instituto Nacional de Enfermedades Neoplasicas (INEN), Peru

• Gustavo Sandival, MD, Hospital Regional Guillermo Diaz de la Vega, Peru

• Iván Lyra González, MD, Servicio de Oncología Clínica, Hospital de Clínicas, Uruguay

Julie Gralow is the Chief Medical Officer (CMO) of the American Society of Clinical Oncology (ASCO). Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN).